Posted: Mar 22, 2022 in Newsletter

March 2022 Newsletter

Newsletter Header Mar 2022

Hi everyone,

I hope you are having a wonderful day!

All of us at API are gearing up to attend some very interesting events this year and we aim to keep promoting the life sciences and technology innovation sector in Western Canada. We’re also looking forward to participating in key committees and councils to share recommendations on provincial and federal life sciences and economic policies. These would greatly benefit Canadians by revitalizing the Alberta region, promote it as a key destination for Life Sciences innovation and commercialization, and attract more investments into the region.

We recently announced a very interesting collaboration with Pfizer and University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences (FoPPS). You can find more details about this announcement in this newsletter.

As promised, this newsletter will give you a quick snapshot of what we’re doing, and how you can get involved in the life sciences ecosystem. If you’re interested in working with us as a network member, client, or trainee, you can contact us at contact@appliedpharma.ca, or reach out on Twitter and Linkedin.

Until next time,

The API Team

API News

API becomes a member of ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working Group by the Government of Alberta

The provincial government announced, ‘The Edmonton Metro Region Economic Recovery (EMRER)’ Working Group – with an aim to revitalize and attract investment to the Edmonton metropolitan region. 

We’re excited to share that API will be one of members of EMRER. We are humbled to be given this opportunity to highlight Edmonton region’s economic strengths in innovation, research, technological excellence, and talent development capabilities. We look forward to collaborating with other members of the EMRER working group.

Read full release here.


Pfizer, Applied Pharmaceutical Innovation and University of Alberta launch the Pfizer Applied Clinical Pharmacology Program

The Pfizer Applied Clinical Pharmacology Program is a multi-year program created by Applied Pharmaceutical Innovation (API) in partnership with the Faculty of Pharmacy and Pharmaceutical Sciences (FoPPS) at University of Alberta with support from members of the Global Clinical Pharmacology team at Pfizer. The program aims to strengthen development and learning opportunities for students interested in the industry applications of pharmacokinetics, including advanced modeling, as well as the regulatory pathway of drugs.


Applied Pharmaceutical Innovation (API) completes clinical trial material production for the ‘Canadian Maraviroc Randomized Controlled Trial to Augment Rehabilitation Outcomes After Stroke’ (CAMAROS) study

A team of scientists led by Dr. Sean Dukelow of the University of Calgary is looking to add a new treatment to help stroke patients recover better from motor impairments. CAMAROS is a multicenter clinical trial to repurpose the use of Maraviroc drug in post-stroke patients undergoing rehabilitation treatment. Dr. Dukelow is working with teams across 8 locations in Canada to conduct the clinical trial.


API joins the Canadian Chamber of Commerce-Member network and the Life Sciences Strategy Council

Applied Pharmaceutical Innovation (API) announced that it is formally a member of the Canadian Chamber of Commerce and will join the ‘Life Sciences Strategy Council’ of the Canadian Chamber of Commerce. The latter has partnered with public and private sector leaders to create a globally competitive, integrated life sciences sector that spans the entire spectrum of activities from research through manufacturing to the commercialization of innovations.

People of API

Micheal Guirguis, Director, Clinical and Data Services: Why drug development

The innovative treatments we help create, improve the health outcomes and/or provide relief from chronic pain for countless patients. This video of Micheal Guirguis, Director, Clinical and Data Services at API captures this emotion beautifully.

In this video, Micheal Guirguis shares why working in the Life Sciences and drug development is important to him. Micheal’s passion is evident and is something we all share at API – we’re doing this to make a difference in people’s lives.

Watch this video to hear it directly from Micheal.


Jieyu Zuo

New at API

We’re thrilled to introduce you to our new team member, Jieyu Zuo.

“I am very passionate about my work in formulation development, quality control, and traditional Chinese medicine. With API’s extensive network of partners, clients, and their project based training model, I feel like this the perfect place to start my career.

There are continuous opportunities to work with experts and learn skills in different stages of drug development.”

Jieyu holds a Ph.D. in Pharmaceutical Sciences with years of experience in formulation development, quality control and traditional Chinese herbal medicine. Jieyu started her journey with API as a postdoctoral fellow and she was working closely with our team on real-world industry projects. Jieyu is now part of our team as a Research Scientist.

Welcome Jieyu!

Upcoming Events and Opportunities
Screen Shot 2022 03 24 at 10.18.47 AM

Economic Development Leaders’ Summit and Conference – Xperience 2022

Economic Developers Alberta is hosting its yearly event Xperience 2022 that brings together Alberta’s most innovative economic development leaders for a series of panel discussions, conferences and networking. This event is a great way to gain insights on what’s happening in our province. 

API is one of the sponsors for the event and we’re looking forward to connecting with industry leaders from Alberta, and learning about the current and emerging sector opportunities, economic development issues and trends, and best practices for reinvention.


Screen Shot 2022 03 09 at 11.31.37 AM

Alberta Technology Symposium

The Canadian Blockchain Consortium is hosting the Alberta Technology Symposium, a two-day exploration of our province’s emerging tech companies, organizations and solutions. 

The event will see participation from leaders across key disciplines like blockchain, fintech, healthcare and sustainability, this landmark event showcases the diverse ways that homegrown technologies are reimagining Alberta’s future and highlights how our tech ecosystem can attract new investment and support innovation hubs with long-term sustainability.

Andrew MacIsaac will be part of panel discussion on the transformations in health technologies. The panel will be held on Day 2 of the event between 1:30 PM – 2:30 PM MST.


CELS Valley Ready (VR) program

The CELS Valley Ready (VR) program is a comprehensive series of activities to coach, promote and connect participating Canadian Life Science Companies to raise Pre-Seed to Series A funding.

Local Life Science & Innovation News

Home-Grown Talent: Brian Corrigan, Global Head, Clinical Pharmacology, Pfizer and member of API’s Scientific Advisory Committee

Brian Corrigan, Vice President and Global Head of Clinical Pharmacology, and Head of Clinical Pharmacology for Global Product Development at Pfizer in Groton, Connecticut, sat down with our team virtually to talk about his career journey, his passion for Clinical Pharmacology and Pharmacometrics, and his thoughts on Canada’s life sciences ecosystem.


Opinion: Data a gold mine of knowledge and opportunity — if we knock down barriers

We leave a constant stream of digital fingerprints — data — from multiple interactions in our daily lives. The analytical yield of data collected from millions of these interactions is a gold mine of knowledge. That knowledge, when used to inform decision-making, has the power to improve the lives of all Canadians and drive economic growth.


Health Innovation Hub -Library Resources and Research for Entrepreneurs

The Health Innovation Hub at the University of Alberta shared a recent presentation on library resources for entrepreneurs.


Supporting STEM learning opportunities for women

To ensure that more women have the opportunity to pursue post-secondary education in STEM programs, the Government of Albertahas approved new funding of $1 million, being provided through bursary programs at Bow Valley College in Calgary and NorQuest College and Yellowhead Tribal College, both in Edmonton.


To view the online version of the newsletter and subscribe, click the below link: https://mailchi.mp/appliedpharma/march-2022-newsletter-5126801

Posted by: API

On Mar 22, 2022 in Newsletter